Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Is It Time To Reassess Exact Sciences (EXAS) After The US$105 Abbott Offer?

If you are wondering whether Exact Sciences is still worth your attention at current prices, the key question is how its market value compares with what the business may be worth on paper. The stock last closed at US$103.24, with returns of 0.1% over 7 days, 1.0% over 30 days, 1.5% year to date, 109.4% over 1 year, 62.6% over 3 years, and a 30.2% decline over 5 years. Recent news around Exact Sciences has focused on its position in cancer diagnostics and how its core products fit into...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Can Oklo's (OKLO) Fuel Recycling Grant Quietly Redefine Its Long-Term Competitive Moat?

The U.S. Department of Energy recently awarded Oklo funding to study how radioactive materials in used nuclear fuel behave in hot liquid salt, supporting the design of its planned commercial fuel recycling facility in Tennessee. This work could help Oklo close the nuclear fuel loop by turning spent fuel into a resource, potentially reducing waste and differentiating its advanced reactor model from other nuclear developers. We’ll now examine how this federal backing for Oklo’s fuel recycling...
NYSE:AON
NYSE:AONInsurance

Is Aon (AON) Pricing Offer An Opportunity After Recent Share Price Weakness

If you are wondering whether Aon is pricing in too much optimism or not enough, this article will walk through what its current share price might be implying about value. The stock last closed at US$321.70, with returns of 5.9% decline over 7 days, 7.0% decline over 30 days, 6.6% decline year to date, 16.2% decline over 1 year, 6.3% gain over 3 years and 46.5% gain over 5 years. This gives you a mix of shorter term weakness and longer term strength to think about. Recent coverage has focused...
NasdaqGS:KPTI
NasdaqGS:KPTIBiotechs

Karyopharm Therapeutics (KPTI) TTM US$196 Million Loss Tests Bullish Profitability Narratives

Karyopharm Therapeutics FY 2025 earnings snapshot Karyopharm Therapeutics (KPTI) closed FY 2025 with Q4 revenue of US$34.1 million and a basic EPS loss of US$5.68, alongside a net loss of US$102.2 million. On a trailing twelve month basis, EPS stood at a loss of US$17.93 on revenue of US$146.1 million and a net loss of US$196.0 million. The company has reported quarterly revenue ranging from US$30.0 million to US$44.0 million over the past year, with basic EPS losses between US$2.77 and...
NYSE:AL
NYSE:ALTrade Distributors

Air Lease Merger Talks Test Earnings Strength And Low P E Valuation

Air Lease (NYSE:AL) is working through a pending merger with Sumisho Air Lease Corporation that could reshape how the business is organized and funded. The potential transaction raises questions around future operations, financing options, and how the combined entity might serve airline customers. Investors are watching closely as the company evaluates this merger alongside its current trading level near $64.73 per share. With Air Lease trading around $64.73, investors are weighing this...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

A Look At Evolv Technologies Holdings (EVLV) Valuation After New Sports Venue Deals And Board Appointment

Evolv Technologies Holdings (EVLV) has drawn fresh attention after securing new deployments of its AI-based weapons detection systems at major US sports venues, alongside appointing Axon executive Henrik Kühl to its board and audit committee. See our latest analysis for Evolv Technologies Holdings. The recent sports venue wins and board changes come after a mixed stretch for the stock, with a 7 day share price return of 3.46% but a 30 day share price decline of 13.68%. At the same time, the 1...
NYSE:ATI
NYSE:ATIAerospace & Defense

Why ATI (ATI) Is Up 7.8% After Strong Q4 Results And Major Buyback Completion

In early February 2026, ATI Inc. reported fourth-quarter 2025 sales of US$1,177.1 million with net income of US$96.6 million, while full-year sales rose to US$4,587.4 million and net income to US$404.3 million, alongside the completion of a US$580.16 million buyback covering 8,343,988 shares since September 2024. Management highlighted that robust aerospace and defense demand, a richer mix of proprietary alloys, and expanded long-term agreements supported stronger-than-expected non-GAAP...
TSX:MG
TSX:MGAuto Components

Magna International (TSX:MG) Margins Hold At 2.5% Net Level Challenging Bullish Expansion Narratives

Magna International (TSX:MG) has put fresh numbers on the table, with Q3 FY 2025 revenue of US$10.5 billion and basic EPS of US$1.08, alongside net income of US$305 million, setting the tone for its latest update. The company has seen quarterly revenue move from US$10.1 billion in Q1 FY 2025 to US$10.6 billion in Q2 and US$10.5 billion in Q3, while basic EPS shifted from US$0.52 to US$1.35 and then US$1.08 over the same stretch. This gives investors a clearer view of how earnings track...
NYSE:BKE
NYSE:BKESpecialty Retail

Should Broad-Based Comparable Sales Growth Shape Buckle’s (BKE) Long-Term Investment Narrative?

The Buckle, Inc. previously reported that net sales for the 4-week fiscal month ended January 31, 2026 rose 3.7% to US$61.8 million, with comparable store gains extending across the fourth quarter and full fiscal year. With full-year net sales increasing to US$1.30 billion and comparable store sales higher across all periods, Buckle’s latest update highlights consistent demand across its store base. Next, we’ll examine how this broad-based comparable sales growth may influence Buckle’s...
NYSE:RWT
NYSE:RWTMortgage REITs

Redwood Trust (RWT) Q4 Revenue Recovery Tests Bullish Narratives On Turnaround Potential

Redwood Trust (RWT) closed out FY 2025 with Q4 total revenue of US$87.3 million and basic EPS of US$0.14, marking a clear rebound from the loss making quarters seen earlier in the year. Over the past few periods, the company has seen revenue move from US$30.9 million in Q4 2024 to US$73.8 million in Q1 2025, fall to US$54.4 million in Q3, then climb to US$87.3 million in Q4. Basic EPS shifted from US$0.09 in Q1 2025 to a loss of US$0.76 in Q2 and back into positive territory in Q4. For...
TSX:MRT.UN
TSX:MRT.UNREITs

Morguard REIT Q4 FFO Loss Challenges Bullish Recovery Narratives

Morguard Real Estate Investment Trust (TSX:MRT.UN) has just wrapped up FY 2025 with Q4 revenue of CA$61.4 million, a basic EPS loss of CA$0.11 per unit, and funds from operations of CA$33.4 million reported as a loss. Over recent periods the trust has seen quarterly revenue move from CA$67.9 million in Q4 2024 to CA$61.4 million in Q4 2025, while basic EPS has ranged from a loss of CA$0.55 per unit in Q4 2024 to mixed results through 2025, including a Q3 EPS of CA$0.07 per unit. For...